PSYK ETF

The PSYK ETF (NYSE: PSYK) is comprised of a portfolio of companies that are involved in the research, development, production and/or use of psychedelics to address medical conditions in legal pharmacological applications in multiple jurisdictions. While psychedelic drugs have been around for millenniums, we believe that we are on the cusp of realizing their true potential to disrupt the psychiatric medical field. Exciting research is discovering the potential of psychedelic drugs – the capability to deliver results in the treatment of mental illness that may exceed traditional pharmacological approaches. The PSYK ETF may offer investors an attractive vehicle to gain exposure to the potentially disruptive medical psychedelics industry. To learn more, please visit www.psyk-etf.com